Immediate Impact
3 by Nobel laureates 4 from Science/Nature 55 standout
Citing Papers
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-II)
2023 Standout
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 3 trial (SLE-BRAVE-I)
2023 Standout
Works of Irène Dobo being referenced
The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera
2006
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Irène Dobo | 274 | 359 | 219 | 20 | 462 | |
| Guntram Buesche | 365 | 360 | 152 | 20 | 476 | |
| Nabih Maslah | 285 | 290 | 207 | 30 | 442 | |
| А К Голенков | 354 | 228 | 124 | 14 | 433 | |
| Yoshitaka Sunami | 258 | 299 | 240 | 18 | 436 | |
| Mayuka Nakatake | 237 | 222 | 245 | 14 | 426 | |
| Selçuk Sözer | 289 | 317 | 230 | 21 | 464 | |
| Valentina Carrai | 218 | 217 | 145 | 26 | 458 | |
| Ronan Chaligné | 290 | 318 | 221 | 11 | 431 | |
| Hideo Hyodo | 296 | 211 | 212 | 17 | 503 | |
| Ladan Duvillié | 373 | 252 | 66 | 19 | 477 |
All Works
Loading papers...